MAM
CoinDCX ropes in Ayushmann Khurrana for its latest campaign
Mumbai: After a spate of campaigns revolving around the ease of investing in cryptocurrencies, homegrown crypto exchange platform CoinDCX has now launched a mega drive to address key concerns surrounding crypto investments amongst the Indian audience. Coined as ‘future yahi hai,’ the campaign will see leading Bollywood actor Ayushmann Khurrana educate young Indians about crypto being ‘simple and safe’ to invest in.
The kickoff ad to be released during the festive season will feature the actor taking a humorous yet informative approach to crypto. The idea to bring on board a superstar like Ayushmann Khurrana comes into play to dismiss myths related to crypto, stated the brand.
“Ayushmann has always come across as being a friendly and credible personality who has a knack for connecting with both younger and older generations with his exemplary work,” said CoinDCX head of brand, marketing and communications Ramalingam Subramanian. “Our focus during this campaign will be to dispel the various myths surrounding crypto-based investing and breaking down the simple steps needed to enable anyone to start their crypto investment journey.”
With its ‘future yahi hai’ campaign, CoinDCX continues with its approach of adopting a simple but engaging narrative to connect with both seasoned and new investors by demystifying crypto for everyone while developing an understanding of crypto-enabled financial services.
“I am delighted to be associated with the campaign which, in the truest sense, is an initiative to raise awareness about the rising asset class of crypto-based investments,” stated Khurrana. “I am impressed with CoinDCX’s persistent endeavour to guide investors towards making educated and smart investments after thorough research.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
